Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver damage using suicide genes. A model for oval cell activation.

M Bustos1, B Sangro, P Alzuguren

  • 1Division of Hepatology and Gene Therapy, Clinica Universitaria and Medical School, University of Navarra, Pamplona. CSIC, Madrid, Spain. mbustos@unav.es

The American Journal of Pathology
|August 10, 2000
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of potassium bromate as a positive control in the in vivo Fpg-modified comet assay for the detection of oxidised bases.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2025
Same author

Transarterial chemoembolisation with irinotecan (irinotecan-TACE) as salvage or post-inductive therapy for colorectal cancer liver metastases: effectiveness results from the CIREL study.

ESMO open·2025
Same author

Transarterial Radioembolisation with Y90 Resin Microspheres and the Effect of Reimbursement Criteria in France: Final Results of the CIRT-FR Prospective Observational Study.

Cardiovascular and interventional radiology·2025
Same author

Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Efficacy and Safety of Preoperative Transcatheter Rectal Arterial Chemoembolisation in Patients with Locally Advanced Rectal Cancer: Results from a Prospective, Phase II PCAR Trial.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024

Adenovirus-mediated gene transfer of thymidine kinase followed by ganciclovir caused liver damage. Severe damage activated oval cells, leading to ductular hyperplasia, fibrosis, and potentially cancer, impairing liver regeneration.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Oncology

Background:

  • Liver regeneration can occur via facultative hepatic stem cells (oval cells) when hepatocyte regeneration is blocked.
  • Existing models to study oval cell response often involve carcinogens and partial hepatectomy.

Purpose of the Study:

  • To investigate the effect of adenovirus-mediated thymidine kinase gene transfer followed by ganciclovir administration on liver regeneration and oval cell response in rats.
  • To determine the dose-dependent toxicity and long-term consequences of this gene therapy approach.

Main Methods:

  • Adenovirus-mediated gene transfer of the thymidine kinase suicide gene into rat livers.
  • Administration of ganciclovir to induce cell death and subsequent liver damage.
  • Assessment of liver architecture, oval cell activation, ductular hyperplasia, fibrosis, and molecular markers (fibronectin, hepatic stellate cells, hepatocyte growth factor).

Related Experiment Videos

Main Results:

  • Hepatotoxicity varied with dose; moderate damage allowed recovery, while severe damage led to persistent oval cell activation and ductular hyperplasia.
  • Severe liver damage progressed to cholangiofibrosis in some rats and cholangiocarcinoma in one.
  • Fibronectin deposition, increased hepatic stellate cells, and hepatocyte growth factor overexpression were associated with severe oval cell response and fibrotic lesions.

Conclusions:

  • Adenovirus-mediated thymidine kinase/ganciclovir therapy can activate oval cell response in the liver.
  • High doses of this therapy induce significant liver damage, impairing hepatocellular regeneration and potentially leading to chronic liver disease and cancer.